With the Spike & Go, pharmacists can now provide the first chemotherapy product that comes in a premixed, ready-to-infuse formulation called INFUGEM™ by Sun Pharma. This alcohol-free, clear, colorless, sterile solution of 10mg/mL gemcitabine in 0.9% sodium chloride involves dose banding practice, whereby standardized doses of intravenous cytotoxic drugs are used for ranges (or “bands”) of doses calculated for individual patients.
The patients who receive this prepared bag in combination with other drugs are treating their breast, ovarian, non-small cell lung cancers, and as a single agent for the treatment of pancreatic cancer.
INFUGEM improves provider and patient experiences by using high-tech delivery systems for novel medicines. The package minimizes the risk of manual compounding and drug contamination and reduces the complexity of infusion.
The Spike & Go with INFUGEM is the first product using Sun’s proprietary technology that allows cytotoxic oncology products to be premixed in a sterile environment and supplied to the prescribers in ready-to-infuse final dosage bags.
Sun Pharma is the world's 4th largest generic pharmaceutical company and No. 1 in India.
Marti Jones brings more than 20 years of integrated communications experience from world-renowned organizations. Marti’s career has grown from raising awareness and funds for the American Red Cross before and after 9/11 to leading strategy for brands such as Mayo Clinic, Duke Health, and M Health Fairview, which included communications for change management and COVID-19. Marti's messaging portfolios are supported by her academic background and proven methodology, as she taught writing at the University of Minnesota and honed her craft at UnitedHealth, UCare, and RXinsider, Revel Health and Hill and Knowlton. Marti received her master’s degree in public affairs and administration from George Washington University and Bachelor of Arts degrees in communications and psychology from Augustana University.
This post is related to:
Generics, Brand Name, Biotech
